Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities (2019)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/dmm.036806
PubMed Identifier: 30692144
Publication URI: http://europepmc.org/abstract/MED/30692144
Type: Journal Article/Review
Parent Publication: Disease Models & Mechanisms
ISSN: 1754-8403